Ross Osborn

Stock Analyst at Cantor Fitzgerald

(0)
# 4449
Out of 5,380 analysts
118
Total ratings
Success rate
Average return
24 Stocks
Name Action PT Current % Upside Ratings Updated
XGN Exagen
Maintains: Overweight
8 7
7.01 -0.14% 6 May 15, 2025
LUCD Lucid Diagnostics
Reiterates: Overweight
2 2
1.2 66.67% 6 May 15, 2025
NPCE NeuroPace
Reiterates: Overweight
17 17
10.73 58.43% 6 May 14, 2025
SIBN SI-BONE
Reiterates: Overweight
25 25
17.81 40.37% 9 May 6, 2025
NNOX Nano X Imaging
Maintains: Overweight
12 9
5.2 73.08% 11 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
46 46
28.36 62.2% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8 8
1.75 357.14% 10 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24 24
10.17 135.99% 3 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
13 13
5.96 118.12% 3 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.37 191.97% 4 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
9 9
8.12 10.84% 7 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.04 122.77% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
21 21
4.92 326.83% 10 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
7.88 103.05% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
14 14
6.06 131.02% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
96
84.69 13.35% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.2 191.67% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
0.77 224.68% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
n/a n/a 5 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
3.45 44.93% 2 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9
0.6 1335% 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 21
n/a n/a 2 Apr 22, 2022